0.0050
0.0000
(0.00%)
At close: August 2 at 2:14:34 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Peter Rizakos | CFO & Director | 134.04k | -- | -- |
Braxia Scientific Corp.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform. The company is headquartered in Toronto, Ontario.
Corporate Governance
Braxia Scientific Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 26, 2025 at 10:59 AM UTC - March 3, 2025 at 12:00 PM UTC
Braxia Scientific Corp. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
HAVLF HAVN Life Sciences Inc.
0.0010
0.00%
IOBT IO Biotech, Inc.
0.8710
+1.79%
MDMA.CN Pharmala Biotech Holdings Inc.
0.3100
+16.98%
ATNF 180 Life Sciences Corp.
1.5100
0.00%
ATAI Atai Life Sciences N.V.
1.5000
-7.41%
GRCE Grace Therapeutics, Inc.
4.1900
+0.96%
DRUG Bright Minds Biosciences Inc.
38.89
-5.24%
MNMD Mind Medicine (MindMed) Inc.
6.93
-1.98%
AXSM Axsome Therapeutics, Inc.
80.05
-3.05%
INO Inovio Pharmaceuticals, Inc.
1.9800
-5.26%